ConductScience.org, home

Paper7909866

Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes' C colorectal carcinoma. German Cancer Aid 17-1A Study Group.

Riethmüller G and 9 others. Lancet, 1994. Cited by 603 papers, by iCite.

Cite this record

ConductScience Library. Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes' C colorectal carcinoma. German Cancer Aid 17-1A Study Group. Papers, record 7909866. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7909866

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes' C colorectal carcinoma. German Cancer Aid 17-1A Study Group.
PubMed
Journal
Lancet
PubMed
Year
1994
PubMed
Publication types
Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial
PubMed
Citations, by iCite
603
iCite
Relative citation ratio, by iCite
15.7
iCite
Revised in PubMed
2019-06-11
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Riethmüller GG
2Schneider-Gädicke EE
3Schlimok GG
4Schmiegel WW
5Raab RR
6Höffken KK
7Gruber RR
8Pichlmaier HH
9Hirche HH
10Pichlmayr RR

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antibodies, MonoclonalMajor topic
Antigens, NeoplasmMajor topic
Colorectal NeoplasmsMajor topic
Chemotherapy, Adjuvant
Female
Humans
Male
Middle Aged
Neoplasm Metastasis
Neoplasm Recurrence, Local
Neoplasm Staging
Patient Compliance
Proportional Hazards Models
Survival Analysis

Source PubMed

Download CSV of topics

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment in7909862Minimal residual disease as the target for immunotherapy of cancer.https://conductscience.org/library/papers/7909862

Source PubMed

Download CSV of comments and corrections

Cited by120

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 603 citations.

PMIDTitleJournalYearIn PapersSource
39595576High-Affinity Fully Human Anti-EpCAM Antibody with Biased IL-2 Exhibits Potent Antitumor Activity.Biomolecules2024https://conductscience.org/library/papers/39595576PubMed
38194912Immune evasion of dormant disseminated tumor cells is due to their scarcity and can be overcome by T cell immunotherapies.Cancer Cell2024https://conductscience.org/library/papers/38194912PubMed
38151631Unraveling the multifaceted role of EpCAM in colorectal cancer: an integrated review of its function and interplay with non-coding RNAs.Med Oncol2023https://conductscience.org/library/papers/38151631PubMed
38004421A Critical Analysis of the FDA's Omics-Driven Pharmacodynamic Biomarkers to Establish Biosimilarity.Pharmaceuticals (Basel)2023https://conductscience.org/library/papers/38004421PubMed
36369033Understanding the versatile roles and applications of EpCAM in cancers: from bench to bedside.Exp Hematol Oncol2022https://conductscience.org/library/papers/36369033PubMed
35986321Anti-cancer therapeutic strategies based on HGF/MET, EpCAM, and tumor-stromal cross talk.Cancer Cell Int2022https://conductscience.org/library/papers/35986321PubMed
35207472Identification, Culture and Targeting of Cancer Stem Cells.Life (Basel)2022https://conductscience.org/library/papers/35207472PubMed
35013776Preclinical evaluation of [99mTc]Tc-labeled anti-EpCAM nanobody for EpCAM receptor expression imaging by immuno-SPECT/CT.Eur J Nucl Med Mol Imaging2022https://conductscience.org/library/papers/35013776PubMed
33182510Recurrence Risk after Radical Colorectal Cancer Surgery-Less Than before, But How High Is It?Cancers (Basel)2020https://conductscience.org/library/papers/33182510PubMed
32764280Epithelial Cell Adhesion Molecule: An Anchor to Isolate Clinically Relevant Circulating Tumor Cells.Cells2020https://conductscience.org/library/papers/32764280PubMed
32507912Expression and function of epithelial cell adhesion molecule EpCAM: where are we after 40 years?Cancer Metastasis Rev2020https://conductscience.org/library/papers/32507912PubMed
32046162Revisiting the Roles of Pro-Metastatic EpCAM in Cancer.Biomolecules2020https://conductscience.org/library/papers/32046162PubMed
31426611Cancer Stem Cells and Targeting Strategies.Cells2019https://conductscience.org/library/papers/31426611PubMed
29845054Targeting Colorectal Cancer Cell Lines Using Nanobodies; AgSK1as a Potential Target.Iran J Biotechnol2017https://conductscience.org/library/papers/29845054PubMed
29329202EpCAM Immunotherapy versus Specific Targeted Delivery of Drugs.Cancers (Basel)2018https://conductscience.org/library/papers/29329202PubMed
28531111Target Therapies for Uterine Carcinosarcomas: Current Evidence and Future Perspectives.Int J Mol Sci2017https://conductscience.org/library/papers/28531111PubMed
28301271Emerging trends and new developments in monoclonal antibodies: A scientometric analysis (1980-2016).Hum Vaccin Immunother2017https://conductscience.org/library/papers/28301271PubMed
27330354Reduction in membranous immunohistochemical staining for the intracellular domain of epithelial cell adhesion molecule correlates with poor patient outcome in primary colorectal adenocarcinoma.Curr Oncol2016https://conductscience.org/library/papers/27330354PubMed
26569228Exploring Different Strategies for Efficient Delivery of Colorectal Cancer Therapy.Int J Mol Sci2015https://conductscience.org/library/papers/26569228PubMed
26550566Production of monoclonal antibodies in plants for cancer immunotherapy.Biomed Res Int2015https://conductscience.org/library/papers/26550566PubMed

See all 120 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/7909866

GET https://conductscience.org/api/papers/v1/7909866/cited_by?page=2